SCHEMBL5283576

SCHEMBL5283576

CC(N)C(=O)C(c1c[nH]cn1)[C@H](N)C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL679593 1.00 SLC7A5 (0.33) SLC7A5
SCHEMBL52161 1.00 SLC7A5 (0.33) SLC7A5
SCHEMBL719518 0.98 SLC7A5 (0.32) SLC7A5
SCHEMBL4939776 0.98 SLC7A5 (0.32) SLC7A5
SCHEMBL667476 0.83
SCHEMBL17627358 0.83
SCHEMBL6156936 0.82
SCHEMBL27768915 0.82 AKR1B1 (0.30)
SCHEMBL28059879 0.82 AKR1B1 (0.30)
SCHEMBL7052027 0.81 SLC7A5 (0.38) SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3250579-A1 SUGAR-DIPEPTIDE CONJUGATES AS FLAVOR MOLECULES Nestec S.A. (CH) 2017-12-06 EP disclosed
WO-2016120257-A1 SUGAR-DIPEPTIDE CONJUGATES AS FLAVOR MOLECULES NESTEC S.A. (CH) 2016-08-04 WO disclosed
WO-2006103274-A9 AGE INHIBITORS PHARMAMENS (FR) 2007-01-18 WO disclosed
EP-0666753-A1 METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES PEPTIDE TECHNOLOGY LTD (AU) 1995-08-16 EP disclosed
EP-0666753-A4 METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES. PEPTIDE TECHNOLOGY LTD (AU) 1995-01-26 EP disclosed
EP-0571390-A4 THE DELAY, PREVENTION AND/OR REVERSAL OF CELL SENESCENCE PEPTIDE TECHNOLOGY LTD (AU) 1994-08-24 EP disclosed
EP-0571390-A1 THE DELAY, PREVENTION AND/OR REVERSAL OF CELL SENESCENCE PEPTIDE TECHNOLOGY LTD (AU) 1993-12-01 EP disclosed
WO-1993004690-A1 METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES PEPTIDE TECHNOLOGY LIMITED (AU) 1993-03-18 WO disclosed
WO-1992009298-A1 THE DELAY, PREVENTION AND/OR REVERSAL OF CELL SENESCENCE PEPTIDE TECHNOLOGY LTD. (AU) 1992-06-11 WO disclosed